Ignite Creation Date:
2024-05-06 @ 7:59 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06200233
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-09
First Post:
2023-12-28
Brief Title:
Rivoceranib in Patients With Metastatic Thymic Epithelial Tumor
Sponsor:
Samsung Medical Center
Organization:
Samsung Medical Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-12-28
First Submit QC Date:
December 28 2023
Study First Post Date:
2024-01-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-08
Last Update Post Date:
2024-04-09
Last Update Post Date Type:
ACTUAL